Metabolic-Fit / 100
Livea review
Livea is one of the few names here with a history that predates the GLP-1 boom — it operates as Livea Medical, PLLC under Minnesota Weight Control, Inc., a weight-management business rather than a telehealth startup. Compounded semaglutide starts at $99 a month and tirzepatide at $199 "when available", a qualification most sellers leave out. It also does something unusual in its own FAQ: it puts its price next to the brand-name alternative, "compared to $1,000+ per month for brand-name Ozempic or Wegovy".
- HSA / FSA-eligible
- Editor-vetted
- No insurance needed
Elena Voss is a mother writing for mothers, not a treating clinician, and holds no medical license. Every clinical figure in this piece is cited inline to its primary source — the trial or the FDA label — so you can open it and check us. This is background reading, not medical advice.
Livea at a glance
- Semaglutide
- From $99/mo
- Tirzepatide
- From $199/mo, when available
- Coverage
- Not published; a Minnesota company offering virtual care
- Brand-name
- Compounded only
How we scored Livea
Every factor comes from Livea's own published pricing, disclosures and oversight, and the six combine into the 46/100 Metabolic-Fit Score by the same weighted six-factor framework we apply to every provider — never nudged by whether a provider pays us.
Cost is unpredictable or sits at the premium end.
No postpartum or breastfeeding framing — a generic weight program.
Thin on the hormonal picture that drives many mothers' weight.
Support is thin once the prescription ships.
Oversight and lab support fall short of the top of this roster — the review below says exactly where.
Exit terms are the weak point: lock-in, notice periods, or a cancellation you have to chase.
How we verified this review
- Last verified
- August 2026
- Confidence
- medium
- Primary source
- livea.com/glp-1
Read from Livea's own pages in August 2026. It operates as Livea Medical, PLLC under Minnesota Weight Control, Inc. — an established weight-management company rather than a new telehealth brand. Compounded semaglutide starts at $99 a month and compounded tirzepatide at $199 "when available", a supply qualification the site states itself and most sellers omit. Both figures appear inside a collapsed FAQ entry rather than on a pricing page, alongside the site's own comparison to "$1,000+ per month for brand-name Ozempic or Wegovy". The compounding pharmacies are described as accredited but are not named, and no list of states is published.
What to expect when you sign up
We walked Livea's public signup funnel (August 2026) — a first-hand look at the flow. We don't create accounts, enter medical data, or complete checkout, so this is what any visitor sees, not a patient outcome.
- 1The signup call to action stays on livea.com (https://livea.com/get-started/)
What we noticed
- No monthly price is visible on the public homepage; the number appears only after you begin the intake
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded semaglutide | $99 | Starting price"Livea offers compounded semaglutide starting at $99/month — compared to $1,000+ per month for brand-name Ozempic or Wegovy." |
| Compounded tirzepatide | $199 | Starting price, subject to availability"Compounded tirzepatide starts at $199/month when available." The availability caveat is the site's own. |
Swipe the table to see plan details →
Many HSA and FSA plans cover GLP-1 telehealth — check yours. These figures are what Livea's own site disclosed at last review; this market re-prices often, so confirm the current number at the source.
What we like
- Operates as a named medical entity, Livea Medical, PLLC, under an established weight-control company rather than a bare LLC
- $99 a month for compounded semaglutide is well below this roster's median
- Says "when available" about tirzepatide instead of implying continuous supply
- Puts its own price beside the brand-name cost in its FAQ rather than leaving the comparison implicit
- Offers a free consultation before any commitment
The caveats
- Both prices are "starting at", so dose may move them
- Tirzepatide availability is explicitly conditional, so the $199 may not be obtainable when you need it
- No list of states served is published
- The compounding pharmacies are described only as "accredited" and are not named
- Pricing appears only inside a collapsed FAQ entry rather than on a pricing page
- No published street address for the medical entity
Livea for mothers: our verdict
Livea is one of the few names here with a history that predates the GLP-1 boom — it operates as Livea Medical, PLLC under Minnesota Weight Control, Inc., a weight-management business rather than a telehealth startup. Compounded semaglutide starts at $99 a month and tirzepatide at $199 "when available", a qualification most sellers leave out. It also does something unusual in its own FAQ: it puts its price next to the brand-name alternative, "compared to $1,000+ per month for brand-name Ozempic or Wegovy". It runs about $99/month — toward the affordable end of what we track.
We weigh Livea the way mothers actually have to: not just the monthly cost, but postpartum and breastfeeding timing and PCOS and insulin resistance — the parts a general weight-loss roundup leaves out.
What Livea costs, in full
- Compounded semaglutide — Starting price: $99/mo
- Compounded tirzepatide — Starting price, subject to availability: $199/mo
That sits below the roughly $179 median ongoing price across the providers we track for mothers — a real cost advantage.
Livea says the price covers the provider visit and the medication. That is the comparison that matters at this price: two providers a few dollars apart can differ by a hundred a month once the extras are counted, so line up what each one bundles before you decide.
The medications Livea prescribes
Livea prescribes semaglutide and tirzepatide — the two with the largest published weight-loss effects, and carrying both on one account matters when insulin resistance, common with PCOS and after gestational diabetes, makes tirzepatide the better-suited option. These are compounded formulations from a licensed pharmacy — the reason the price stays down — but compounded GLP-1s aren't FDA-approved finished products the way Wegovy and Zepbound are.
Where Livea fits — and where it doesn't — for mothers
A good fit if…
- the monthly cost is a real barrier and you want a low, predictable number.
- switching between semaglutide and tirzepatide may become necessary as your body and your hormones change.
Look elsewhere if…
- you specifically want an FDA-approved brand pen with its own pregnancy and lactation labeling.
- you'd rather a prescriber talk through timing around postpartum and breastfeeding timing — that is the ground our #1 pick, CoreAge Rx, is built on.
Oversight, safety, and what we could verify
Our confidence is moderate — the core facts check out, but some details (per-state availability, program mechanics) aren't fully public. As with any compounded GLP-1, the most useful thing mothers can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our scoring methodology.
One line that applies to every provider on this site: no GLP-1 is established as safe in pregnancy or while breastfeeding, and the labels advise against use. This is a review of a commercial program, not a green light — the timing decision belongs to you and your clinician.
The bottom line
Livea is a genuine value play — weigh it on postpartum and breastfeeding timing and PCOS and insulin resistance against the alternatives below. For most mothers, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.
The bottom line for mothers
Best for: Someone who wants a company with a track record behind the prescription rather than a new domain.
Alternatives to Livea
Providers we have a referral relationship with, ordered by their Metabolic-Fit Score — highest first. This module leaves out the provider whose page you are reading, so on CoreAge Rx's own review our #1 pick is the one name you will not find here. These are not the whole roster: see the full ranking for every provider we cover, paid or not.
- Visit CoreAge Rx92
Metabolic-Fit / 100
CoreAge RxOur #1 pickOne flat price, both molecules on a single chart, and a prescriber who reads your history before writing — the most predictable place for a mother to start and, just as important, to pause.
- Visit Gala Health84
Metabolic-Fit / 100
A flat $179 for either molecule with a genuinely gentle microdosing tier — a reasonable, all-doses-included option if you can live with a yearly plan and a pharmacy it doesn't name.
- Visit Enhance MD81
Metabolic-Fit / 100
One of the more oversight-forward compounded programs here — lab work and a live provider visit bundled into every plan, with a gentle microdosing tier — the catch is that the low '$212' headline you'll see quoted is the 12-month prepay rate, not the $249 you'd pay month to month.
Keep comparing Livea
Head-to-head & alternatives
Livea, answered
- How much does Livea cost?
- At last review, Livea's lowest ongoing compounded rate was about $99 a month — From $99/mo for semaglutide, From $199/mo, when available for tirzepatide. This market re-prices often, so check the current all-in figure at the source before committing.
- Is Livea safe to use while breastfeeding?
- Nothing in this class — compounded or brand — has been established as safe in pregnancy or lactation, and every label advises against use. Livea is not an exception to that. Plan a GLP-1 for after weaning and settle the timing with your own clinician.
- Does Livea offer both semaglutide and tirzepatide?
- Yes — Livea offers both molecules. Tirzepatide's dual GIP/GLP-1 action is often preferred where insulin resistance drives weight, which matters for PCOS and after gestational diabetes.
- Where does Livea rank for mothers?
- Livea scores 46/100 on our Metabolic-Fit Score and sits at #138. That score is a weighted read of six things mothers actually have to care about. CoreAge Rx currently leads it — see how they compare.
Pricing, states and verification reflect Livea's public disclosures at last review; the Metabolic-Fit Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.